NO20075541L - Mono-lysine salter av azolforbindelser - Google Patents
Mono-lysine salter av azolforbindelserInfo
- Publication number
- NO20075541L NO20075541L NO20075541A NO20075541A NO20075541L NO 20075541 L NO20075541 L NO 20075541L NO 20075541 A NO20075541 A NO 20075541A NO 20075541 A NO20075541 A NO 20075541A NO 20075541 L NO20075541 L NO 20075541L
- Authority
- NO
- Norway
- Prior art keywords
- mono
- compounds
- fungal
- formula
- triazole
- Prior art date
Links
- 150000003851 azoles Chemical class 0.000 title abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 3
- 230000000843 anti-fungal effect Effects 0.000 abstract 2
- 150000003852 triazoles Chemical class 0.000 abstract 2
- 206010017533 Fungal infection Diseases 0.000 abstract 1
- 208000031888 Mycoses Diseases 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- -1 triazole compounds Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/26—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one amino group bound to the carbon skeleton, e.g. lysine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Det tilveiebringes mono-lysinsalter av triazolforbindelser som har en sekundær eller tertiær hydroksygruppe. Mer spesielt tilveiebringes det nye, vannoppløselige triazol-anti-sopp-mono-lysinsaltforbindelser eller solvater derav, som har den generelle formel I: hvor A i formel I representerer ikke-hydroksy-delen av en triazol-anti-sopp-forbindelse av typen inneholdende en sekundær eller tertiær hydroksylgmppe. R og Ri formel I kan hver være et hydrogenatom eller en alkylgruppe som har ett til seks karbonatomer.De nye, vannoppløselige azol-forbindelsene er anvendelige for behandling av soppinfeksjoner, og kan administreres oralt, topisk og parenteralt.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US67693205P | 2005-05-03 | 2005-05-03 | |
| PCT/JP2006/309435 WO2006118351A1 (en) | 2005-05-03 | 2006-05-01 | Mono-lysine salts of azole compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20075541L true NO20075541L (no) | 2007-11-28 |
Family
ID=36910951
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20075541A NO20075541L (no) | 2005-05-03 | 2007-11-02 | Mono-lysine salter av azolforbindelser |
Country Status (34)
| Country | Link |
|---|---|
| US (1) | US20060264406A1 (no) |
| EP (1) | EP1877403B1 (no) |
| JP (1) | JP4015691B1 (no) |
| KR (1) | KR100887044B1 (no) |
| CN (1) | CN101213193B (no) |
| AR (1) | AR053862A1 (no) |
| AT (1) | ATE503753T1 (no) |
| AU (1) | AU2006241694B2 (no) |
| BR (1) | BRPI0610423B8 (no) |
| CA (1) | CA2606185C (no) |
| CY (1) | CY1111569T1 (no) |
| DE (1) | DE602006020998D1 (no) |
| DK (1) | DK1877403T3 (no) |
| EC (1) | ECSP077812A (no) |
| ES (1) | ES2361768T3 (no) |
| HK (1) | HK1117502A1 (no) |
| HR (1) | HRP20110467T1 (no) |
| IL (1) | IL187059A (no) |
| JO (1) | JO2691B1 (no) |
| MX (1) | MX2007013605A (no) |
| MY (1) | MY138095A (no) |
| NO (1) | NO20075541L (no) |
| NZ (1) | NZ563092A (no) |
| PE (1) | PE20071423A1 (no) |
| PL (1) | PL1877403T3 (no) |
| PT (1) | PT1877403E (no) |
| RS (1) | RS51779B (no) |
| RU (1) | RU2399625C2 (no) |
| SA (1) | SA06270126B1 (no) |
| SI (1) | SI1877403T1 (no) |
| TW (1) | TWI363630B (no) |
| UY (1) | UY29507A1 (no) |
| WO (1) | WO2006118351A1 (no) |
| ZA (1) | ZA200709127B (no) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1964843B1 (en) | 2005-12-20 | 2013-08-28 | Eisai R&D Management Co., Ltd. | Process for production of water-soluble azole prodrug |
| DE602007009489D1 (de) | 2006-02-22 | 2010-11-11 | Eisai R&D Man Co Ltd | Stabilisierte pharmazeutische zusammensetzung |
| CN105287403A (zh) * | 2014-08-02 | 2016-02-03 | 陕西合成药业股份有限公司 | 一种泊沙康唑前体药物的冻干组合物及其制备方法和用途 |
| CN106432338A (zh) * | 2015-08-08 | 2017-02-22 | 陕西合成药业股份有限公司 | 泊沙康唑衍生物、合成和在长效制剂中的用途 |
| WO2019106571A1 (en) | 2017-11-28 | 2019-06-06 | Roivant Sciences Gmbh | Dosing regimens for the treatment of fungal infections |
| CN110938093B (zh) * | 2018-09-21 | 2022-08-19 | 华创合成制药股份有限公司 | 一种泊沙康唑磷酸酯单胆碱盐及其制备方法和用途 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ278882A (en) * | 1994-01-24 | 1997-06-24 | Janssen Pharmaceutica Nv | Piperazine-containing azole antifungal compounds |
| NZ270418A (en) * | 1994-02-07 | 1997-09-22 | Eisai Co Ltd | Polycyclic triazole & imidazole derivatives, antifungal compositions |
| US5883097A (en) * | 1998-04-16 | 1999-03-16 | Schering Corporation | Soluble azole antifungal salt |
| US6265584B1 (en) * | 1998-05-22 | 2001-07-24 | Bristol-Myers Squibb Company | Water soluble prodrugs of azole compounds |
| AU1915500A (en) * | 1998-11-20 | 2000-06-13 | Bristol-Myers Squibb Company | Water soluble prodrugs of azole compounds |
| US6235728B1 (en) * | 1999-02-19 | 2001-05-22 | Bristol-Myers Squibb Company | Water-soluble prodrugs of azole compounds |
| US6362172B2 (en) * | 2000-01-20 | 2002-03-26 | Bristol-Myers Squibb Company | Water soluble prodrugs of azole compounds |
| US6448401B1 (en) * | 2000-11-20 | 2002-09-10 | Bristol-Myers Squibb Company | Process for water soluble azole compounds |
-
2006
- 2006-04-17 JO JO2006103A patent/JO2691B1/en active
- 2006-04-28 MY MYPI20061985A patent/MY138095A/en unknown
- 2006-04-28 UY UY29507A patent/UY29507A1/es active IP Right Grant
- 2006-05-01 CN CN2006800150290A patent/CN101213193B/zh not_active Expired - Fee Related
- 2006-05-01 RU RU2007140788/04A patent/RU2399625C2/ru active
- 2006-05-01 EP EP06746245A patent/EP1877403B1/en active Active
- 2006-05-01 KR KR1020077001773A patent/KR100887044B1/ko active IP Right Grant
- 2006-05-01 JP JP2007509811A patent/JP4015691B1/ja active Active
- 2006-05-01 DK DK06746245.7T patent/DK1877403T3/da active
- 2006-05-01 CA CA2606185A patent/CA2606185C/en active Active
- 2006-05-01 DE DE602006020998T patent/DE602006020998D1/de active Active
- 2006-05-01 AU AU2006241694A patent/AU2006241694B2/en not_active Ceased
- 2006-05-01 AT AT06746245T patent/ATE503753T1/de active
- 2006-05-01 ES ES06746245T patent/ES2361768T3/es active Active
- 2006-05-01 WO PCT/JP2006/309435 patent/WO2006118351A1/en active Application Filing
- 2006-05-01 PL PL06746245T patent/PL1877403T3/pl unknown
- 2006-05-01 MX MX2007013605A patent/MX2007013605A/es active IP Right Grant
- 2006-05-01 NZ NZ563092A patent/NZ563092A/en not_active IP Right Cessation
- 2006-05-01 SI SI200630984T patent/SI1877403T1/sl unknown
- 2006-05-01 BR BRPI0610423A patent/BRPI0610423B8/pt active IP Right Grant
- 2006-05-01 PT PT06746245T patent/PT1877403E/pt unknown
- 2006-05-01 RS RS20110275A patent/RS51779B/en unknown
- 2006-05-02 PE PE2006000458A patent/PE20071423A1/es active IP Right Grant
- 2006-05-02 AR ARP060101759A patent/AR053862A1/es not_active Application Discontinuation
- 2006-05-03 TW TW095115682A patent/TWI363630B/zh not_active IP Right Cessation
- 2006-05-03 US US11/416,322 patent/US20060264406A1/en not_active Abandoned
- 2006-05-03 SA SA06270126A patent/SA06270126B1/ar unknown
-
2007
- 2007-10-16 EC EC2007007812A patent/ECSP077812A/es unknown
- 2007-10-23 ZA ZA200709127A patent/ZA200709127B/en unknown
- 2007-10-31 IL IL187059A patent/IL187059A/en active IP Right Grant
- 2007-11-02 NO NO20075541A patent/NO20075541L/no not_active Application Discontinuation
-
2008
- 2008-07-14 HK HK08107745.5A patent/HK1117502A1/xx unknown
-
2011
- 2011-06-17 CY CY20111100582T patent/CY1111569T1/el unknown
- 2011-06-21 HR HR20110467T patent/HRP20110467T1/hr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20075541L (no) | Mono-lysine salter av azolforbindelser | |
| CY1120559T1 (el) | Παραγωγα 1-(ακετυλ)-πιπεριδινης και 1-(ακετυλ)-πιπεραζινης ως μυκητοκτονα για χρηση στη φυτοπροστασια | |
| NO20084179L (no) | Fremgangsmate for produksjon av 4-oksokinolinforbindelser | |
| NO20062517L (no) | 2-cyanopyrrolidinkarboksamidforbindelse | |
| NO20083717L (no) | Pyrrolotriazin-anilin prodrugforbindelser anvendbare som kinaseinhibitorer | |
| ATE554065T1 (de) | Sulfoniumsalz-fotoinitiatoren | |
| NO20074093L (no) | Fremgangsmater for fremstilling av glukopyranosyl-substituerte benzyl-benzenderivater og mellomprodukter derav | |
| TN2010000052A1 (fr) | Derives de pyrazole et leur utilisation comme inhibiteurs de raf | |
| MX2009013254A (es) | Derivados 3-amino-6(1-amino-etil)-tetrahidropirano. | |
| NO20064003L (no) | Nyekarboksamider for anvendelse som XA-inhibitorer | |
| TW200720399A (en) | Light-emitting element and iridium complex | |
| JP2015504112A5 (no) | ||
| NO20082630L (no) | Vann-opploslige benzoazepinforbindelser og farmasoytisk forbindelse | |
| NO20065573L (no) | Orto-substituerte aryl eller heteroarylamidforbindelser | |
| NO20081930L (no) | Oksazolforbindelser og farmasoytiske blandinger | |
| EA200800813A1 (ru) | Фунгицидные пиридинилоксизамещённые производные фениламидина | |
| WO2005116023A8 (en) | 3- {4- (pyridin-3-yl) phenyl} -5- (1h-1, 2, 3-triazol-1-ylmethyl) -1, 3-oxazolidin-2-ones as antibacterial agents | |
| WO2009041095A1 (ja) | 染毛用染料及び染毛用組成物 | |
| EP2020617A3 (en) | Resist composition containing a sulfonium compound, pattern-forming method using the resist composition, and sulfonium compound | |
| TW200637539A (en) | CTGF inhibitors | |
| MY142821A (en) | Polyvinylammonium compound, method of manufacturing same, acidic solution containing said compound and method of electrolytically depositing a copper deposit | |
| BRPI0502897A (pt) | compostos corantes | |
| GEP20115166B (en) | 2-ARYLINDOLE DERIVATIVES AS mPGES-I INHIBITORS | |
| WO2006021653A3 (fr) | Derives d'azasucre, inhibiteurs d'heparanases, leur procede de preparation, les compositions en contenant, leur utilisation | |
| WO2009069312A1 (ja) | （１ｈ－１，２，４－トリアゾール－１－イル）アリール化合物及びその製造方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |